The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Progression-free survival (PFS) in unresectable melanoma patients (pts) treated with talimogene laherparepvec (T-VEC) versus granulocyte macrophage colony-stimulating factor (GM-CSF) in OPTiM.
 
Mohammed M. Milhem
Honoraria - Amgen; Blueprint Medicines; Immunocore; Trieza
Consulting or Advisory Role - Amgen; Blueprint Medicines; Immunocore; Trieza Therapeutics
Research Funding - Amgen (Inst); ER Squibb & Sons (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Prometheus (Inst)
 
Kevin J. Harrington
Honoraria - Amgen; AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Pfizer; Replimune
Consulting or Advisory Role - Amgen (Inst); AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Merck Serono (Inst); Merck Sharp & Dohme; Pfizer (Inst)
Speakers' Bureau - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme
Research Funding - AstraZeneca (Inst); Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim
 
Frances A. Collichio
Consulting or Advisory Role - Amgen
Research Funding - Amgen; Merck; Novartis
Travel, Accommodations, Expenses - Genentech
Other Relationship - ACGME
 
Thomas Amatruda
Research Funding - Amgen (Inst); Brystol-Myers-Squibb (Inst); Merck (Inst)
Other Relationship - Amgen
 
Jason Alan Chesney
Consulting or Advisory Role - Amgen; Replimune
Research Funding - Amgen; Bristol-Myers Squibb; Iovance Biotherapeutics; MedImmune; MedImmune; Replimune
Patents, Royalties, Other Intellectual Property - University of Louisville US Patents
Travel, Accommodations, Expenses - Amgen; Replimune
 
Sanjiv S. Agarwala
Consulting or Advisory Role - MSD
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD
 
Sumita Bhatta
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Min Yi
Employment - Amgen
Stock and Other Ownership Interests - Amgen
Travel, Accommodations, Expenses - Amgen
 
Mark R. Middleton
Honoraria - Amgen; Roche
Consulting or Advisory Role - BiolineRx; Bristol-Myers Squibb; CytomX Therapeutics; Immunocore; Johnson & Johnson; Merck; Newlink Genetics; Novartis; RigonTEC
Research Funding - Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Immunocore (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Regeneron (Inst); Replimune (Inst); RigonTEC (Inst); Roche (Inst); TC Biopharm (Inst); Vertex (Inst)
Travel, Accommodations, Expenses - Merck
 
Merrick I. Ross
Honoraria - Amgen; Merck
Consulting or Advisory Role - Amgen; Merck
Speakers' Bureau - Amgen
Research Funding - Amgen (Inst)
Travel, Accommodations, Expenses - Amgen; Merck
 
Igor Puzanov
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Roche/Genentech
Travel, Accommodations, Expenses - Amgen; Merck